Because of the higher expression of PD-L1 on tumors and PD-1 on antigen-specific T cells after Neo-Lpx vaccination, we examined whether combining anti-PD-1 with the lipoplex vaccine approach might further block tumor growth. Here, CD274 is linked to neoplasm.